Ahmad Hamad1, Wesley A Burks2. 1. Division of Allergy and Immunology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC, 27517, USA. ahama@med.unc.edu. 2. Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, USA.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to highlight the recent advances in food desensitization in children with food allergy. RECENT FINDINGS: Recent advancements in epicutaneous, sublingual, and oral immunotherapy for food allergy in the future may offer children with food allergy and their families a viable option to reduce risk or severity of anaphylaxis with phase III trials ongoing for two of these treatment modalities. Food allergy prevalence in children is estimated to be up to 8%. These children are at risk of significant allergic reactions and anaphylaxis. Food avoidance and use of antihistamines or epinephrine has been the standard of care for these patients. This approach also has a significant socioeconomic effects on patients and their families. Recent advancements in understanding food allergy have allowed for exploring new methods of treatment. There is an increasing interest in oral immunotherapy, epicutaneous immunotherapy, or sublingual immunotherapy for food allergy. There have been also innovative approaches to immunotherapy by modification of food allergens (to make them less allergenic while maintain their immunogenicity) or adding adjunctive treatments (probiotics, anti-IgE, etc.) to increase efficacy or safety.
PURPOSE OF REVIEW: The purpose of this review is to highlight the recent advances in food desensitization in children with food allergy. RECENT FINDINGS: Recent advancements in epicutaneous, sublingual, and oral immunotherapy for food allergy in the future may offer children with food allergy and their families a viable option to reduce risk or severity of anaphylaxis with phase III trials ongoing for two of these treatment modalities. Food allergy prevalence in children is estimated to be up to 8%. These children are at risk of significant allergic reactions and anaphylaxis. Food avoidance and use of antihistamines or epinephrine has been the standard of care for these patients. This approach also has a significant socioeconomic effects on patients and their families. Recent advancements in understanding food allergy have allowed for exploring new methods of treatment. There is an increasing interest in oral immunotherapy, epicutaneous immunotherapy, or sublingual immunotherapy for food allergy. There have been also innovative approaches to immunotherapy by modification of food allergens (to make them less allergenic while maintain their immunogenicity) or adding adjunctive treatments (probiotics, anti-IgE, etc.) to increase efficacy or safety.
Authors: Corinne A Keet; Pamela A Frischmeyer-Guerrerio; Ananth Thyagarajan; John T Schroeder; Robert G Hamilton; Stephen Boden; Pamela Steele; Sarah Driggers; A Wesley Burks; Robert A Wood Journal: J Allergy Clin Immunol Date: 2011-11-30 Impact factor: 10.793
Authors: Julie Wang; Stacie M Jones; Jacqueline A Pongracic; Ying Song; Nan Yang; Scott H Sicherer; Melanie M Makhija; Rachel G Robison; Erin Moshier; James Godbold; Hugh A Sampson; Xiu-Min Li Journal: J Allergy Clin Immunol Date: 2015-06-01 Impact factor: 10.793
Authors: Hugh A Sampson; Donald Y M Leung; A Wesley Burks; Gideon Lack; Sami L Bahna; Stacie M Jones; Dennis A Wong Journal: J Allergy Clin Immunol Date: 2011-03-11 Impact factor: 10.793
Authors: Satya D Narisety; Pamela A Frischmeyer-Guerrerio; Corinne A Keet; Mark Gorelik; John Schroeder; Robert G Hamilton; Robert A Wood Journal: J Allergy Clin Immunol Date: 2014-12-18 Impact factor: 10.793
Authors: Carmen García-Ara; María Pedrosa; María Teresa Belver; María Flor Martín-Muñoz; Santiago Quirce; Teresa Boyano-Martínez Journal: Ann Allergy Asthma Immunol Date: 2013-02-14 Impact factor: 6.347
Authors: P Rodríguez del Río; A Díaz-Perales; S Sanchez-García; C Escudero; Patricia do Santos; M Catarino; M D Ibañez Journal: J Investig Allergol Clin Immunol Date: 2014 Impact factor: 4.333
Authors: Stefania Arasi; Iris M Otani; Erik Klingbeil; Philippe Bégin; Clare Kearney; Tina Lr Dominguez; Whitney M Block; Geraldine O'Riordan; Kari C Nadeau Journal: Allergy Asthma Clin Immunol Date: 2014-11-25 Impact factor: 3.406
Authors: Philippe Bégin; Lisa C Winterroth; Tina Dominguez; Shruti P Wilson; Liane Bacal; Anjuli Mehrotra; Bethany Kausch; Anthony Trela; Elisabeth Hoyte; Gerri O'Riordan; Scott Seki; Alanna Blakemore; Margie Woch; Robert G Hamilton; Kari C Nadeau Journal: Allergy Asthma Clin Immunol Date: 2014-01-15 Impact factor: 3.406
Authors: Philippe Bégin; Tina Dominguez; Shruti P Wilson; Liane Bacal; Anjuli Mehrotra; Bethany Kausch; Anthony Trela; Morvarid Tavassoli; Elisabeth Hoyte; Gerri O'Riordan; Alanna Blakemore; Scott Seki; Robert G Hamilton; Kari C Nadeau Journal: Allergy Asthma Clin Immunol Date: 2014-02-20 Impact factor: 3.406
Authors: J Andrew Bird; Mario Sánchez-Borges; Ignacio J Ansotegui; Motohiro Ebisawa; José Antonio Ortega Martell Journal: World Allergy Organ J Date: 2018-12-07 Impact factor: 4.084